Nesbitt T, Drezner M K
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
Endocrinology. 1990 Aug;127(2):843-8. doi: 10.1210/endo-127-2-843.
Previous investigations have established that hypophosphatemic (Hyp) mice exhibit diminished PTH/cAMP stimulation of 25-hydroxyvitamin D (25[OH]D)-1-hydroxylase activity in the renal proximal convoluted tubule. Whether similar muted enzyme responsiveness occurs secondary to provocation by other hormones/metabolic factors that operate by a different mechanism in the same cell system, however, remains unknown. In order to investigate this possibility, we compared renal 25(OH)D-1-hydroxylase activity of normal and Hyp mice upon stimulation with PTH-related peptide (PTHrP), a factor which may affect enzyme function in the PCT by a PTH-independent mechanism. Administration of 1-34 PTHrP, 3.0 micrograms/day sc, increased enzyme activity in normal mice (4.9 + 0.63 vs. 50.3 +/- 6.2 fmol/mg kidney.min) to a level significantly greater than that achieved in the Hyp mice (6.9 + 0.86 vs. 14.5 +/- 0.91 fmol/mg kidney.min). Moreover, similar to our observations after PTH stimulation, abnormal PTHrP effects did not result from an altered time course of enzyme activation or a shift in the dose response. Thus, the 25(OH)D-1-hydroxylase activity increased linearly to a maximum at 24 h in both animal models with a slope greater in normals than in mutants (P less than 0.05). Further, administration of PTHrP in graded amounts (0-9.0 micrograms/day) elicited a curvilinear response in normals and Hyp mice, but the mutants exhibited significantly less function (54 +/- 8.6%) at all doses tested. Additional studies revealed that the muted effects of PTHrP occurred via a PTH-independent mechanism. In this regard, we observed that simultaneous infusion of maximally effective doses of PTH and PTHrP in normal and Hyp mice resulted in an additive increment of 25(OH)D-1-hydroxylase activity. This observation that PTH and PTHrP influence renal 25(OH)D-1-hydroxylase by apparently different mechanisms indicates that the muted effects of these agents on enzyme activity in the Hyp-mouse results from a generalized defect in the proximal convoluted tubule.
先前的研究已证实,低磷血症(Hyp)小鼠肾近端曲管中甲状旁腺激素(PTH)/环磷酸腺苷(cAMP)对25-羟基维生素D(25[OH]D)-1-羟化酶活性的刺激作用减弱。然而,在同一细胞系统中,由其他通过不同机制起作用的激素/代谢因子激发后,是否会出现类似的酶反应减弱情况仍不清楚。为了探究这种可能性,我们比较了正常小鼠和Hyp小鼠在用甲状旁腺激素相关肽(PTHrP)刺激后的肾25(OH)D-1-羟化酶活性,PTHrP是一种可能通过不依赖PTH的机制影响近端小管中该酶功能的因子。皮下注射1-34 PTHrP,剂量为3.0微克/天,可使正常小鼠的酶活性增加(4.9 + 0.63对50.3 +/- 6.2 fmol/毫克肾脏·分钟),达到显著高于Hyp小鼠的水平(6.9 + 0.86对14.5 +/- 0.91 fmol/毫克肾脏·分钟)。此外,与我们在PTH刺激后的观察结果相似,PTHrP的异常作用并非源于酶激活时间进程的改变或剂量反应的偏移。因此,在两种动物模型中,25(OH)D-1-羟化酶活性在24小时内均呈线性增加至最大值,正常小鼠的斜率大于突变小鼠(P < 0.05)。此外,给予不同剂量(0 - 9.0微克/天)的PTHrP在正常小鼠和Hyp小鼠中均引发了曲线反应,但在所有测试剂量下,突变小鼠的功能均显著较低(54 +/- 8.6%)。进一步的研究表明,PTHrP的减弱作用是通过不依赖PTH的机制发生的。在这方面,我们观察到在正常小鼠和Hyp小鼠中同时输注最大有效剂量的PTH和PTHrP会导致25(OH)D-1-羟化酶活性的累加增加。PTH和PTHrP显然通过不同机制影响肾25(OH)D-1-羟化酶,这一观察结果表明,这些药物对Hyp小鼠中酶活性的减弱作用是由近端曲管中的普遍缺陷导致的。